Skip to main content
Top
Published in: Inflammation 3/2013

01-06-2013

Oligopeptidases B from Trypanossoma cruzi and Trypanossoma brucei Inhibit Inflammatory Pain in Mice by Targeting Serotoninergic Receptors

Authors: Rafaela Quintanilha Abrahão, Adriano Cardoso Franciosi, Douglas Andrade, Luiz Juliano, Maria Aparecida Juliano, Renata Giorgi, Camila Squarzoni Dale

Published in: Inflammation | Issue 3/2013

Login to get access

Abstract

In the present study, the antinociceptive profile of oligopeptidases B from Trypanosoma cruzi (OPTc) and Trypanosoma brucei (OPTb) were examined in mice evaluated by the acetic acid-induced writhing test. Both OPTc and OPTb injected intraperitoneally attenuated the writhing numbers in the acetic acid-induced writhing test. This effect was not dependent on the enzymatic activity, but the enzyme structure was important for this purpose. Intraperitoneal pretreatment with methysergide (5-HT serotonergic receptor antagonist) attenuated antinociceptive effect induced by both OPTc and OPTb in the writhing test. However, naloxone (opioid receptor antagonist) or yohimbine (α2-adrenergic receptor antagonist) did not affect antinociception induced by both oligopeptidases. Our results suggest that OPTc and OPTb show antinociceptive property in the writhing test. Furthermore, this antinociceptive effect may be mediated by serotonergic receptor but not opioidergic or α2-adrenergic receptors.
Literature
1.
go back to reference Rawlings, N.D., F.R. Morton, C.Y. Kok, J. Kong, and A.J. Barrett. 2008. MEROPS: the peptidase database. Nucleic Acids Research 36: D320–325.PubMedCrossRef Rawlings, N.D., F.R. Morton, C.Y. Kok, J. Kong, and A.J. Barrett. 2008. MEROPS: the peptidase database. Nucleic Acids Research 36: D320–325.PubMedCrossRef
2.
go back to reference Gerczei, T., G.M. Keseru, and G. Naray-Szabo. 2000. Construction of a 3D model of oligopeptidase B, a potential processing enzyme in prokaryotes. Journal of Molecular Graphics and Modelling 7–17: 57–58. Gerczei, T., G.M. Keseru, and G. Naray-Szabo. 2000. Construction of a 3D model of oligopeptidase B, a potential processing enzyme in prokaryotes. Journal of Molecular Graphics and Modelling 7–17: 57–58.
3.
go back to reference de Matos-Guedes, H.L., M.P. Duarte-Carneiro, D.C. de Oliveira-Gomes, B. Rossi-Bergmann, and S. Giovanni-de-Simone. 2007. Oligopeptidase B from Leishmania amazonensis: molecular cloning, gene expression analysis and molecular model. Parasitology Research 101: 865–875.PubMedCrossRef de Matos-Guedes, H.L., M.P. Duarte-Carneiro, D.C. de Oliveira-Gomes, B. Rossi-Bergmann, and S. Giovanni-de-Simone. 2007. Oligopeptidase B from Leishmania amazonensis: molecular cloning, gene expression analysis and molecular model. Parasitology Research 101: 865–875.PubMedCrossRef
4.
go back to reference Polgar, L. 1997. A potential processing enzyme in prokaryotes: oligopeptidase B, a new type of serine peptidase. Proteins 28: 375–379.PubMedCrossRef Polgar, L. 1997. A potential processing enzyme in prokaryotes: oligopeptidase B, a new type of serine peptidase. Proteins 28: 375–379.PubMedCrossRef
5.
go back to reference Pacaud, M., and C. Richaud. 1975. Protease II from Escherichia coli. Purification and characterization. Journal of Biological Chemistry 250: 7771–7779.PubMed Pacaud, M., and C. Richaud. 1975. Protease II from Escherichia coli. Purification and characterization. Journal of Biological Chemistry 250: 7771–7779.PubMed
6.
go back to reference Nishicata, N. 1984. Trypsin-like protease from soybean seeds. Purification and some properties. Journal of Biochemistry 95: 1169–1177. Nishicata, N. 1984. Trypsin-like protease from soybean seeds. Purification and some properties. Journal of Biochemistry 95: 1169–1177.
7.
go back to reference Kornblatt, M.J., G.W.N. Mpimbaza, and J.D. Lonsdale-Eccles. 1992. Characterization of an endopeptidase of Trypanosoma brucei. Archives of Biochemistry and Biophysics 293: 25–31.PubMedCrossRef Kornblatt, M.J., G.W.N. Mpimbaza, and J.D. Lonsdale-Eccles. 1992. Characterization of an endopeptidase of Trypanosoma brucei. Archives of Biochemistry and Biophysics 293: 25–31.PubMedCrossRef
8.
go back to reference Bongertz, V., and K.D. Hungerer. 1978. Trypanosoma cruzi: isolation and characterization of a protease. Experimental Parasitol 45: 8–18.CrossRef Bongertz, V., and K.D. Hungerer. 1978. Trypanosoma cruzi: isolation and characterization of a protease. Experimental Parasitol 45: 8–18.CrossRef
9.
go back to reference Tsuji, A., K. Yuasa, and Y. Matsuda. 2004. Identification of oligopeptidase B in higher plants. Purification and characterization of oligopeptidase B from quiescent wheat embryo, Triticum aestivum. Journal of Biochemistry 136: 673–681.PubMedCrossRef Tsuji, A., K. Yuasa, and Y. Matsuda. 2004. Identification of oligopeptidase B in higher plants. Purification and characterization of oligopeptidase B from quiescent wheat embryo, Triticum aestivum. Journal of Biochemistry 136: 673–681.PubMedCrossRef
10.
go back to reference Rea, D., C. Hazell, N.W. Andrews, R.E. Morty, and V. Fulop. 2006. Expression, purification and preliminary crystallographic analysis of oligopeptidase B from Trypanosoma brucei. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications 62: 808–810.PubMedCrossRef Rea, D., C. Hazell, N.W. Andrews, R.E. Morty, and V. Fulop. 2006. Expression, purification and preliminary crystallographic analysis of oligopeptidase B from Trypanosoma brucei. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications 62: 808–810.PubMedCrossRef
11.
go back to reference Usuki, H., Y. Uesugi, M. Iwabuchi, and T. Hatanaka. 2009. Activation of oligopeptidase B from Streptomyces griseus by thiol-reacting reagents is independent of the single reactive cysteine residue. Biochimica et Biophysica Acta 1794: 1673–1683.PubMedCrossRef Usuki, H., Y. Uesugi, M. Iwabuchi, and T. Hatanaka. 2009. Activation of oligopeptidase B from Streptomyces griseus by thiol-reacting reagents is independent of the single reactive cysteine residue. Biochimica et Biophysica Acta 1794: 1673–1683.PubMedCrossRef
12.
go back to reference Coetzer, T.H.T., J.P.D. Goldring, and L.E.J. Huson. 2008. Oligopeptidase B: a processing peptidase involved in pathogenesis. Biochimie 90: 336–344.PubMedCrossRef Coetzer, T.H.T., J.P.D. Goldring, and L.E.J. Huson. 2008. Oligopeptidase B: a processing peptidase involved in pathogenesis. Biochimie 90: 336–344.PubMedCrossRef
13.
go back to reference Burleigh, B.A., and A.M. Woolsey. 2002. Cell signalling and Trypanosoma cruzi invasion. Cellular Microbiology 4: 701–711.PubMedCrossRef Burleigh, B.A., and A.M. Woolsey. 2002. Cell signalling and Trypanosoma cruzi invasion. Cellular Microbiology 4: 701–711.PubMedCrossRef
14.
go back to reference Burleigh, B.A., and N.W. Andrews. 1995. A 120-kDa alkaline peptidase from Trypanosoma cruzi is involved in the generation of a novel Ca2 + —signaling factor for mammalian cells. Journal of Biological Chemistry 270: 5172–5180.PubMedCrossRef Burleigh, B.A., and N.W. Andrews. 1995. A 120-kDa alkaline peptidase from Trypanosoma cruzi is involved in the generation of a novel Ca2 + —signaling factor for mammalian cells. Journal of Biological Chemistry 270: 5172–5180.PubMedCrossRef
15.
go back to reference Burleigh, B.A., E.V. Caler, P. Webster, and N.W. Andrews. 1997. A cytosolic serine endopeptidase from Trypanosoma cruzi is required for the generation of Ca2+ signaling in mammalian cells. The Journal of Cell Biology 136: 609–620.PubMedCrossRef Burleigh, B.A., E.V. Caler, P. Webster, and N.W. Andrews. 1997. A cytosolic serine endopeptidase from Trypanosoma cruzi is required for the generation of Ca2+ signaling in mammalian cells. The Journal of Cell Biology 136: 609–620.PubMedCrossRef
16.
go back to reference Caler, E.V., S. Vaena de Avalos, P.A. Haynes, N.W. Andrews, and B.A. Burleigh. 1998. Oligopeptidase B dependent signaling mediates host cell invasion by Trypanosoma cruzi. EMBO Journal 17: 4975–4986.PubMedCrossRef Caler, E.V., S. Vaena de Avalos, P.A. Haynes, N.W. Andrews, and B.A. Burleigh. 1998. Oligopeptidase B dependent signaling mediates host cell invasion by Trypanosoma cruzi. EMBO Journal 17: 4975–4986.PubMedCrossRef
17.
go back to reference Morty, R.E., R. Pelle, I. Vadasz, G.L. Uzcanga, W. Seeger, and J. Bubis. 2005. Oligopeptidase B from Trypanosoma evansi. A parasite peptidase that inactivates atrial natriuretic factor in the bloodstream of infected hosts. Journal of Biological Chemistry 280: 10925–10937.PubMedCrossRef Morty, R.E., R. Pelle, I. Vadasz, G.L. Uzcanga, W. Seeger, and J. Bubis. 2005. Oligopeptidase B from Trypanosoma evansi. A parasite peptidase that inactivates atrial natriuretic factor in the bloodstream of infected hosts. Journal of Biological Chemistry 280: 10925–10937.PubMedCrossRef
18.
go back to reference Troeberg, L., R.N. Pike, R.E. Morty, R.K. Berry, T.H. Coetzer, and J.D. Lonsdale-Eccles. 1996. Proteases from Trypanosoma brucei brucei. Purification, characterisation and interactions with host regulatory molecules. European Journal of Biochemistry 238: 728–736.PubMedCrossRef Troeberg, L., R.N. Pike, R.E. Morty, R.K. Berry, T.H. Coetzer, and J.D. Lonsdale-Eccles. 1996. Proteases from Trypanosoma brucei brucei. Purification, characterisation and interactions with host regulatory molecules. European Journal of Biochemistry 238: 728–736.PubMedCrossRef
19.
go back to reference Morty, R.E., J.D. Lonsdale-Eccles, R. Mentele, E.A. Auerswald, and T.H. Coetzer. 2001. Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity. Infection and Immunity 69: 2757–2761.PubMedCrossRef Morty, R.E., J.D. Lonsdale-Eccles, R. Mentele, E.A. Auerswald, and T.H. Coetzer. 2001. Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity. Infection and Immunity 69: 2757–2761.PubMedCrossRef
20.
go back to reference Ndung’u, J.M., N.G. Wright, F.W. Jennings, and M. Murray. 1992. Changes in atrial natriuretic factor and plasma renin activity in dogs infected with Trypanosoma brucei. Parasitology Research 78(553): 556. Ndung’u, J.M., N.G. Wright, F.W. Jennings, and M. Murray. 1992. Changes in atrial natriuretic factor and plasma renin activity in dogs infected with Trypanosoma brucei. Parasitology Research 78(553): 556.
21.
go back to reference Morty, R.E., L. Troeberg, R.N. Pike, et al. 1998. A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin. FEBS Letters 433: 251–256.PubMedCrossRef Morty, R.E., L. Troeberg, R.N. Pike, et al. 1998. A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin. FEBS Letters 433: 251–256.PubMedCrossRef
22.
go back to reference Morty, R.E., L. Troeberg, J.C. Powers, S. Ono, J.D. Lonsdale-Eccles, and T.H. Coetzer. 2000. Characterisation of the antitrypanosomal activity of peptidyl alpha-aminoalkyl phosphonate diphenyl esters. Biochemical Pharmacology 60: 1497–1504.PubMedCrossRef Morty, R.E., L. Troeberg, J.C. Powers, S. Ono, J.D. Lonsdale-Eccles, and T.H. Coetzer. 2000. Characterisation of the antitrypanosomal activity of peptidyl alpha-aminoalkyl phosphonate diphenyl esters. Biochemical Pharmacology 60: 1497–1504.PubMedCrossRef
23.
go back to reference Mohd Ismail, N.I., T. Yuasa, K. Yuasa, Y. Nambu, M. Nisimoto, M. Goto, H. Matsuki, M. Inoue, M. Nagahama, and A. Tsuji. 2010. A critical role for highly conserved Glu(610) residue of oligopeptidase B from Trypanosoma brucei in thermal stability. Journal of Biochemistry 147: 201–211.PubMedCrossRef Mohd Ismail, N.I., T. Yuasa, K. Yuasa, Y. Nambu, M. Nisimoto, M. Goto, H. Matsuki, M. Inoue, M. Nagahama, and A. Tsuji. 2010. A critical role for highly conserved Glu(610) residue of oligopeptidase B from Trypanosoma brucei in thermal stability. Journal of Biochemistry 147: 201–211.PubMedCrossRef
24.
go back to reference Zimmermann, M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109–110.PubMedCrossRef Zimmermann, M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109–110.PubMedCrossRef
25.
go back to reference Koster, R., M. Anderson, and E.J. de Beer. 1959. Acetic acid for analgesic screening. Federation Proceedings 18: 412. Koster, R., M. Anderson, and E.J. de Beer. 1959. Acetic acid for analgesic screening. Federation Proceedings 18: 412.
26.
go back to reference Motta, F.N., I.M. Bastos, E. Faudry, C. Ebel, M.M. Lima, D. Neves, M. Ragno, J.A. Barbosa, S.M. de Freitas, and J.M. Santana. 2012. The Trypanosoma cruzi virulence factor oligopeptidase B (OPBTc) assembles into an active and stable dimer. PLoS One 7: e30431.PubMedCrossRef Motta, F.N., I.M. Bastos, E. Faudry, C. Ebel, M.M. Lima, D. Neves, M. Ragno, J.A. Barbosa, S.M. de Freitas, and J.M. Santana. 2012. The Trypanosoma cruzi virulence factor oligopeptidase B (OPBTc) assembles into an active and stable dimer. PLoS One 7: e30431.PubMedCrossRef
27.
go back to reference Collier, H.O.J., L.C. Dinneen, C.A. Johnson, and C. Schneider. 1969. The abdominal constriction response and its suppression by analgesic drugs in the mouse. BritishJournal of Pharmaceutical Chemotherapy 32: 295–310.CrossRef Collier, H.O.J., L.C. Dinneen, C.A. Johnson, and C. Schneider. 1969. The abdominal constriction response and its suppression by analgesic drugs in the mouse. BritishJournal of Pharmaceutical Chemotherapy 32: 295–310.CrossRef
28.
go back to reference Taber, R.I., D.D. Greenhouse, J.K. Rendell, and S. Irwin. 1969. Agonist and antagonist interactions of opioids on acetic acid-induced abdominal stretching in mice. Journal of Pharmacology and Experimental Therapeutics 169: 29–38.PubMed Taber, R.I., D.D. Greenhouse, J.K. Rendell, and S. Irwin. 1969. Agonist and antagonist interactions of opioids on acetic acid-induced abdominal stretching in mice. Journal of Pharmacology and Experimental Therapeutics 169: 29–38.PubMed
29.
go back to reference Smith, T.W., R.L. Follenfant, and S.H. Ferreira. 1985. Antinociceptive models displaying peripheral opioid activity. International Journal of Tissue Reactions 7: 61–67.PubMed Smith, T.W., R.L. Follenfant, and S.H. Ferreira. 1985. Antinociceptive models displaying peripheral opioid activity. International Journal of Tissue Reactions 7: 61–67.PubMed
30.
go back to reference Schmauss, C., and T.L. Yaksh. 1984. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. Journal of Pharmacology and Experimental Therapeutics 228: 1–12.PubMed Schmauss, C., and T.L. Yaksh. 1984. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. Journal of Pharmacology and Experimental Therapeutics 228: 1–12.PubMed
31.
go back to reference Yaksh, T.L. 1984. Multiple opioid receptor systems in brain and spinal cord: part I. European Journal of Anaesthesiology 1: 171–199.PubMed Yaksh, T.L. 1984. Multiple opioid receptor systems in brain and spinal cord: part I. European Journal of Anaesthesiology 1: 171–199.PubMed
32.
go back to reference Yaksh, T.L. 1979. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Research 160: 180–185.PubMedCrossRef Yaksh, T.L. 1979. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Research 160: 180–185.PubMedCrossRef
33.
go back to reference Jensen, T.S., and T.L. Yaksh. 1984. Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites. Brain Research 321: 287–297.PubMedCrossRef Jensen, T.S., and T.L. Yaksh. 1984. Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites. Brain Research 321: 287–297.PubMedCrossRef
34.
go back to reference Wigdor, S., and G.L. Wilcox. 1987. Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. Journal of Pharmacology and Experimental Therapeutics 242: 90–95.PubMed Wigdor, S., and G.L. Wilcox. 1987. Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. Journal of Pharmacology and Experimental Therapeutics 242: 90–95.PubMed
Metadata
Title
Oligopeptidases B from Trypanossoma cruzi and Trypanossoma brucei Inhibit Inflammatory Pain in Mice by Targeting Serotoninergic Receptors
Authors
Rafaela Quintanilha Abrahão
Adriano Cardoso Franciosi
Douglas Andrade
Luiz Juliano
Maria Aparecida Juliano
Renata Giorgi
Camila Squarzoni Dale
Publication date
01-06-2013
Publisher
Springer US
Published in
Inflammation / Issue 3/2013
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9595-1

Other articles of this Issue 3/2013

Inflammation 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.